The Relation between Serum Vitamin D Levels and Blood Pressure: A Population-Based Study
-
Fatemeh Ardeshir Larijani
,
Seyed Mohammad Kalantar Motamedi
,
Abbas Ali Keshtkar
,
Patricia Khashayar
,
Zahra Koleini
,
Fakher Rahim
,
Bagher Larijani
Abstract
Vitamin D deficiency has been proposed as an associating factor with increased blood pressure. We studied the relationship between serum vitamin D and blood pressure in a large representative sample of Iranian population. In this cross-sectional study, based on the data of 2508 adults (aged between 20 and 70 years) from the Iran Multicenter Osteoporosis Study (IMOS), the association between serum vitamin D and blood pressure was investigated. There was a significant difference between mean (±SD) vitamin D levels of the individuals with stage I hypertension and that of the three other groups (Normal: 32.9 (±27.5); Prehypertension: 34.4 (±27.2); Stage-I: 38.7 (±29.2); Stage-II: 34.7 (±24.0) ng/ml; P<0.05. In multivariate regression models, the weak positive association of vitamin D and systolic blood pressure values disappeared after age and Body Mass Index (BMI) adjustment. We found a statistically positive but weak association between vitamin D serum concentration and systolic blood pressure. Considering the difference noted between our results and previous studies, further research is needed to assess the potential effect of ethnicity and genetic factors on these findings.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3(11):e442.
Carretero OA, Oparil S. Essential hypertension: Part i: Definition and etiology. Circulation 2000;101(3):329-35.
Esteghamati A, Meysamie A, Khalilzadeh O, et al. Third national surveillance of risk factors of non-communicable diseases (surfncd-2007) in iran: Methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Publ Health 2009;9:167.
Lips P, Hosking D, Lippuner K, et al. The prevalence of vitamin d inadequacy amongst women with osteoporosis: An international epidemiological investigation. J Intern Med 2006;260(3):245-54.
Maghbooli Z, Hossein‐nezhad A, Karimi F, et al. Correlation between vitamin d3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev 2008;24(1):27-32.
Chiu KC, Chu A, Go VL, et al. Hypovitaminosis d is associated with insulin resistance and ß cell dysfunction. Am J Clin Nutr 2004;79(5):820-5.
Loffreda A, Vitagliano S, de Novellis V, et al. Dietary vitamin D deficiency and development of cardiovascular system Pharmacol Res 1994;22:269-269.
Judd SE, Raiser SN, Kumari M, et al. 1,25- dihydroxyvitamin d3 reduces systolic blood pressure in hypertensive adults: A pilot feasibility study. J Steroid Biochem Mol Biol 2010;121(1-2):445-7.
Li YC, Qiao G, Uskokovic M, et al. Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004;89-90(1-5):387-92.
Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin d, ethnicity, and blood pressure in the third national health and nutrition examination survey. Am J Hypertens 2007;20(7):713-9.
Pan WH, Wang CY, Li LA, et al. No significant effect of calcium and vitamin d supplementation on blood pressure and calcium metabolism in elderly chinese. Chin J Physiol 1993;36(2):85-94.
Lind L, Wengle B, Wide L, et al. Reduction of blood pressure during long-term treatment with active vitamin d (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens 1989;2(1):20-5.
Muray S, Parisi E, Cardús A, et al. Influence of vitamin d receptor gene polymorphisms and 25-hydroxyvitamin d on blood pressure in apparently healthy subjects. J Hypertens 2003;21(11):2069-75.
Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 1980: Systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011;377(9765):568-77.
Farzadfar F, Danaei G, Namdaritabar H, et al. National and subnational mortality effects of metabolic risk factors and smoking in iran: A comparative risk assessment. Popul Health Metr 2011;9(1):55.
Hashemipour S, Larijani B, Adibi H, et al. Vitamin D deficiency and causative factors in the population of tehran. BMC Publ Health 2004;4:38.
Heshmat R, Mohammad K, Majdzadeh S, et al. Vitamin D deficiency in iran: A multi-center study among different urban areas. Iran J Publ Health 2008;37(1):72-8.
Maghbooli Z, Hossein-Nezhad A, Shafaei AR, et al. Vitamin D status in mothers and their newborns in iran. BMC Pregnancy Childbirth 2007;7(1):1.
Hashemipour S, Larijani B, Adibi H, et al. The status of biochemical parameters in varying degrees of vitamin D deficiency. J Bone Miner Metab 2006;24(3):213-8.
Moradzadeh K, Larijani B, Keshtkar A, et al. Normative values of vitamin d among iranian population: A population based study. Int J Osteoporos Metab Disord 2008;1(1):8-15.
Meybodi HRA, Heshmat R, Maasoumi Z, et al. Iranian osteoporosis research network: Background, mission and its role in osteoporosis management. Iran J Publ Health 2008;37(1):1-6.
Lohman TG, Roche AF, Martorell R, editors. Anthropometric standardization reference manual. 1st ed. Michigan: Human Kinetics apub; 1988.
Lau DCW, Douketis JD, Morrison KM, et al. 2006 canadian clinical practice guidelines on the management,and prevention of obesity in adults and children (summary). CMAJ 2007;176(8):S1-13.
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42(6):1206-52.
Scragg RK, Camargo CA Jr, Simpson RU. Relation of serum 25-hydroxyvitamin d to heart rate and cardiac work (from the national health and nutrition examination surveys). Am J Cardiol 2010;105(1):122-8.
Schleithoff SS, Zittermann A, Tenderich G, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006;83(4):754-9.
Sugden J, Davies J, Witham M, et al. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabetic medicine 2008;25(3):320-5.
Krause R, Bühring M, Hopfenmüller W, et al. Ultraviolet b and blood pressure. Lancet 1998;352(9129):709-10.
Bukoski RD, DeWan P, McCarron DA. 1,25 (oh)2 vitamin d3 modifies growth and contractile function of vascular smooth muscle of spontaneously hypertensive rats. Am J Hypertens 1989;2(7):553-6.
Bukoski RD, Wang DB, Wagman DW. Injection of 1,25- (OH)2 vitamin D3 enhances resistance artery contractile properties. Hypertension 1990;16(5):523-31.
Shan J, Resnick LM, Lewanczuk RZ, et al. 1, 25- dihydroxyvitamin d as a cardiovascular hormone. Effects on calcium current and cytosolic free calcium in vascular smooth muscle cells. Am J Hypertens 1993;6(12):983-8.
Forman J, Curhan G, Taylor E. Plasma 25-hydroxyvitamin d levels and risk of incident hypertension among young women. Hypertension 2008;52(5):828-32.
Wang L, Manson JE, Buring JE, et al. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 2008;51(4):1073-9.
Witham MD, Nadir MA, Struthers AD. Effect of vitamin d on blood pressure: A systematic review and meta-analysis. J Hypertens 2009;27(10):1948-54.
Judd SE, Nanes MS, Ziegler TR, et al. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white americans: Results from the third national health and nutrition examination survey. Am J Clin Nutr 2008;87(1):136-41.
Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152(5):307-14.
Mohammadnejad Z, Ghanbari M, Ganjali R, et al. Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in iranian population. Mol Biol Rep 2012;39(2):8311-7.
Aslani S, Hossein-Nezhad A, Mirzaei K, et al. Vdr foki polymorphism and its potential role in the pathogenesis ofgestational diabetes mellitus and its complications. Gynecol Endocrinol 2011;27(12):1055-60.
Hossein-Nezhad A, Ahangari G, Larijani B. Evaluating of vdr gene variation and its interaction with immune regulatory molecules in osteoporosis. Iranian J Publ Health 2009;38(2):27-36.
Margolis KL, Ray RM, Van Horn L, et al. Effect of calcium and vitamin D supplementation on blood pressure: the women's health initiative randomized trial. Hypertension 2008;52(5):847-55.
| Files | ||
| Issue | Vol 52, No 4 (2014) | |
| Section | Original Article(s) | |
| Keywords | ||
| Hypertension Systolic blood pressure Vitamin D Vitamin D deficiency | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
